SRPT vs WT · rev $1.90B vs P/E 44, rev $427.7M
Sarepta Therapeutics Inc (SRPT) versus WisdomTree Inc. (WT) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
WisdomTree Inc. (WT) is a asset management company listed on NYSE.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported WT revenue for 2024-12-31 was $427.7M. Net income was $66.7M. Revenue was up 22.5% from 2023-12-31 to 2024-12-31. WT currently screens at market cap $2.78B and trailing P/E 44.3.
SRPT currently screens at market cap $2.34B. WT currently screens at market cap $2.78B and trailing P/E 44.3.
Not investment advice. Open the SRPT and WT stock pages for the full models.
Not investment advice.